Opportunities Preloader

Please Wait.....

Report

Gene Synthesis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, By Method (Solid-phase Synthesis, Chip-based Synthesis, PCR-based Enzyme Synthesis), By Service (Antibody DNA Synthesis, Viral DNA Synthesis, Others), By Application (Gene & Cell Therapy Development, Vaccine Development, Disease Diagnosis, Others), By End Use (Biotechnology and Pharmaceutical Companies, Academic and Government Research Institutes, Contract Research Organizations), By Region and Competition, 2020-2030F

Market Report I 2025-02-28 I 185 Pages I TechSci Research

Global Gene Synthesis Market was valued at USD 1.84 Billion in 2024 and is expected to reach USD 2.73 Billion by 2030 with a CAGR of 9.76% during the forecast period. The Gene Synthesis market is a burgeoning sector within the biotechnology industry, characterized by the custom production of artificial DNA sequences. It plays a pivotal role in various fields such as genetic engineering, pharmaceuticals, and synthetic biology. The market's growth is primarily driven by advancements in DNA synthesis technologies, reduced costs, and increasing demand for tailored genetic constructs for research and therapeutic purposes.In January 2022, the U.S. Food and Drug Administration (FDA) granted a second approval to Moderna's mRNA-based COVID-19 vaccine, Spikevax. This highlighted the critical role of gene synthesis during the pandemic, with the market anticipated to experience further growth.
With applications ranging from vaccine development to gene therapy, the Gene Synthesis market is poised for continued expansion as it empowers scientists and researchers to design and construct genes with precision, fostering innovation across multiple domains.
Key Market Drivers
Rising investment in synthetic biology market
The rising investment in the synthetic biology market has emerged as a significant driver for the Gene Synthesis market. Synthetic biology, a multidisciplinary field that combines biology with engineering principles, is experiencing a surge in funding and interest from various sectors, including biotechnology, pharmaceuticals, energy, and agriculture. This investment is fundamentally reshaping the landscape of genetic research and applications, with gene synthesis playing a pivotal role. One key aspect of synthetic biology is the design and construction of novel biological parts, devices, and systems. Gene synthesis is the enabling technology that allows scientists and engineers to create custom DNA sequences with precision. As investment in synthetic biology grows, there is a heightened demand for synthesized genes to build and optimize synthetic biological systems. Researchers are increasingly relying on gene synthesis services to design and produce the genetic components required for their projects, from engineered microbes for biomanufacturing to gene circuits for medical applications.
Moreover, the expansion of synthetic biology into diverse industries such as biomanufacturing, biofuels, agriculture, and healthcare is propelling the Gene Synthesis market forward. Investment in these sectors is driving innovation and driving the need for synthetic genes tailored to specific applications. This symbiotic relationship between synthetic biology and gene synthesis is creating a feedback loop, with each field reinforcing the other's growth. Furthermore, the infusion of capital into synthetic biology startups and research initiatives is fostering technological advancements in gene synthesis. Companies are investing in research and development to improve the efficiency, cost-effectiveness, and automation of gene synthesis processes. These innovations are making gene synthesis more accessible and affordable, attracting a broader range of researchers and industries. In conclusion, the rising investment in the synthetic biology market serves as a powerful catalyst for the Gene Synthesis market. It fuels demand for custom DNA sequences, accelerates innovation in genetic engineering, and supports the development of novel applications across various sectors. As synthetic biology continues to flourish, the Gene Synthesis market is likely to see sustained growth and transformation, unlocking new possibilities in biotechnology and beyond.
Key Market Challenges
Lack of skilled professionals
The Gene Synthesis market faces a significant challenge in the form of a shortage of skilled professionals, which poses hurdles to its growth and advancement. This scarcity of expertise impacts various facets of the gene synthesis industry and has multifaceted consequences. Firstly, gene synthesis involves intricate molecular biology techniques and a deep understanding of DNA manipulation. Without a sufficient number of skilled professionals, the industry may experience delays in project timelines, reduced efficiency, and increased risk of errors in synthesized DNA sequences. This shortage of expertise can hinder research and development efforts in areas such as drug discovery, genetic engineering, and synthetic biology, where precision and accuracy are paramount.
Moreover, the lack of skilled professionals limits the capacity for innovation and technological advancement within the Gene Synthesis market. Talented scientists and engineers are essential for driving the development of new synthesis methods, automation technologies, and software tools that enhance the efficiency and capabilities of gene synthesis platforms. Without a skilled workforce, the industry may struggle to keep pace with emerging trends and evolving customer needs. Additionally, as the demand for gene synthesis services grows across diverse industries, there is an increased need for professionals who can not only synthesize genes but also design and optimize genetic constructs for specific applications. The shortage of such specialists can constrain the market's ability to provide tailored solutions to researchers and organizations with unique genetic engineering requirements. Furthermore, the Gene Synthesis market relies on a workforce that understands and adheres to strict ethical and biosecurity standards, especially as concerns about misuse of synthesized DNA arise. Skilled professionals are essential for implementing and enforcing these standards to ensure responsible and secure use of gene synthesis services. To address these challenges, efforts are needed to invest in education and training programs that cultivate a new generation of skilled gene synthesis professionals. Collaboration between academic institutions, industry, and regulatory bodies can help bridge the skills gap and foster a workforce capable of driving innovation and responsible use of gene synthesis technologies. In doing so, the Gene Synthesis market can overcome the obstacle posed by the shortage of skilled professionals and continue to thrive in the era of genetic advancement.
Key Market Trends
Growth in Personalized Medicine
The Gene Synthesis market is experiencing a significant trend driven by the growth of personalized medicine. Personalized medicine involves tailoring medical treatments and interventions to an individual's genetic makeup. This approach requires the development of custom-designed genetic constructs, which is where gene synthesis plays a pivotal role. In January 2024, Twist Bioscience introduced Twist Express Genes, a new service providing high-quality synthetic DNA, including larger DNA preparations of up to 1 milligram, with delivery in as little as five business days.
As personalized medicine gains prominence, the demand for synthesized genes for research, diagnostics, and therapeutic applications surges. Gene synthesis allows the creation of precise genetic tools, such as patient-specific gene therapies, gene editing components, and diagnostic probes. These custom genetic constructs enable healthcare providers to develop treatments that are uniquely suited to an individual's genetic profile, maximizing effectiveness and minimizing adverse effects. The Gene Synthesis market is poised to benefit from this trend, as it becomes an indispensable part of the personalized medicine ecosystem. The ability to rapidly and accurately produce tailored genetic material aligns with the evolving healthcare landscape, offering hope for more effective and personalized medical solutions.
Key Market Players
- OriGene Technologies, Inc.
- Integrated DNA Technologies, Inc.
- ProMab Biotechnologies, Inc.
- Thermo Fisher Scientific, Inc.
- ProteoGenix, Inc.
- Biomatik USA LLC
- Twist Bioscience
- Boster Biological Technology
- Brooks Automation, Inc.
- Genscript Corporation
Report Scope:
In this report, the Global Gene Synthesis Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- Gene Synthesis Market, By Method:
o Solid-phase Synthesis
o Chip-based Synthesis
o PCR-based Enzyme Synthesis
- Gene Synthesis Market, By Service:
o Antibody DNA Synthesis
o Viral DNA Synthesis
o Others
- Gene Synthesis Market, By Application:
o Gene & Cell Therapy Development
o Vaccine Development
o Disease Diagnosis
o Others
- Gene Synthesis Market, By End Use:
o Biotechnology and Pharmaceutical Companies
o Academic and Government Research Institutes
o Contract Research Organizations
- Gene Synthesis Market, By Region:
o North America
United States
Canada
Mexico
o Europe
France
United Kingdom
Italy
Germany
Spain
o Asia-Pacific
China
India
Japan
Australia
South Korea
o South America
Brazil
Argentina
Colombia
o Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Gene Synthesis Market.
Available Customizations:
Global Gene Synthesis market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Gene Synthesis Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Method (Solid-phase Synthesis, Chip-based Synthesis, PCR-based Enzyme Synthesis)
5.2.2. By Service (Antibody DNA Synthesis, Viral DNA Synthesis, Others)
5.2.3. By Application (Gene & Cell Therapy Development, Vaccine Development, Disease Diagnosis, Others)
5.2.4. By End Use (Biotechnology and Pharmaceutical Companies, Academic and Government Research Institutes, Contract Research Organizations)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. North America Gene Synthesis Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Method
6.2.2. By Service
6.2.3. By Application
6.2.4. By End Use
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Gene Synthesis Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Method
6.3.1.2.2. By Service
6.3.1.2.3. By Application
6.3.1.2.4. By End Use
6.3.2. Canada Gene Synthesis Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Method
6.3.2.2.2. By Service
6.3.2.2.3. By Application
6.3.2.2.4. By End Use
6.3.3. Mexico Gene Synthesis Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Method
6.3.3.2.2. By Service
6.3.3.2.3. By Application
6.3.3.2.4. By End Use
7. Europe Gene Synthesis Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Method
7.2.2. By Service
7.2.3. By Application
7.2.4. By End Use
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Gene Synthesis Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Method
7.3.1.2.2. By Service
7.3.1.2.3. By Application
7.3.1.2.4. By End Use
7.3.2. United Kingdom Gene Synthesis Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Method
7.3.2.2.2. By Service
7.3.2.2.3. By Application
7.3.2.2.4. By End Use
7.3.3. Italy Gene Synthesis Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Method
7.3.3.2.2. By Service
7.3.3.2.3. By Application
7.3.3.2.4. By End Use
7.3.4. France Gene Synthesis Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Method
7.3.4.2.2. By Service
7.3.4.2.3. By Application
7.3.4.2.4. By End Use
7.3.5. Spain Gene Synthesis Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Method
7.3.5.2.2. By Service
7.3.5.2.3. By Application
7.3.5.2.4. By End Use
8. Asia-Pacific Gene Synthesis Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Method
8.2.2. By Service
8.2.3. By Application
8.2.4. By End Use
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Gene Synthesis Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Method
8.3.1.2.2. By Service
8.3.1.2.3. By Application
8.3.1.2.4. By End Use
8.3.2. India Gene Synthesis Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Method
8.3.2.2.2. By Service
8.3.2.2.3. By Application
8.3.2.2.4. By End Use
8.3.3. Japan Gene Synthesis Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Method
8.3.3.2.2. By Service
8.3.3.2.3. By Application
8.3.3.2.4. By End Use
8.3.4. South Korea Gene Synthesis Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Method
8.3.4.2.2. By Service
8.3.4.2.3. By Application
8.3.4.2.4. By End Use
8.3.5. Australia Gene Synthesis Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Method
8.3.5.2.2. By Service
8.3.5.2.3. By Application
8.3.5.2.4. By End Use
9. South America Gene Synthesis Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Method
9.2.2. By Service
9.2.3. By Application
9.2.4. By End Use
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Gene Synthesis Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Method
9.3.1.2.2. By Service
9.3.1.2.3. By Application
9.3.1.2.4. By End Use
9.3.2. Argentina Gene Synthesis Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Method
9.3.2.2.2. By Service
9.3.2.2.3. By Application
9.3.2.2.4. By End Use
9.3.3. Colombia Gene Synthesis Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Method
9.3.3.2.2. By Service
9.3.3.2.3. By Application
9.3.3.2.4. By End Use
10. Middle East and Africa Gene Synthesis Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Method
10.2.2. By Service
10.2.3. By Application
10.2.4. By End Use
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Gene Synthesis Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Method
10.3.1.2.2. By Service
10.3.1.2.3. By Application
10.3.1.2.4. By End Use
10.3.2. Saudi Arabia Gene Synthesis Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Method
10.3.2.2.2. By Service
10.3.2.2.3. By Application
10.3.2.2.4. By End Use
10.3.3. UAE Gene Synthesis Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Method
10.3.3.2.2. By Service
10.3.3.2.3. By Application
10.3.3.2.4. By End Use
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Porters Five Forces Analysis
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products
14. Competitive Landscape
14.1. OriGene Technologies, Inc.
14.1.1. Business Overview
14.1.2. Company Snapshot
14.1.3. Products & Services
14.1.4. Financials (As Reported)
14.1.5. Recent Developments
14.1.6. Key Personnel Details
14.1.7. SWOT Analysis
14.2. Integrated DNA Technologies, Inc.
14.3. ProMab Biotechnologies, Inc.
14.4. Thermo Fisher Scientific, Inc.
14.5. ProteoGenix, Inc.
14.6. Biomatik USA LLC
14.7. Twist Bioscience
14.8. Boster Biological Technology
14.9. Brooks Automation, Inc.
14.10. Genscript Corp
15. Strategic Recommendations
16. About Us & Disclaimer

  • Not Sure / Need Reassuring
    • Confirm Content
      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages
      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives
      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices
      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts
      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies
      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses
      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License
      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats
      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery
      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges
      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card
      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer
      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security
      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security
      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE